STEADY-STATE KINETICS OF PYRIDOSTIGMINE IN MYASTHENIA-GRAVIS

被引:20
作者
SORENSEN, PS
FLACHS, H
FRIIS, ML
HVIDBERG, EF
PAULSON, OB
机构
[1] RIGSHOSP,DEPT CLIN CHEM CL,DK-2100 COPENHAGEN,DENMARK
[2] RIGSHOSP,DEPT CLIN PHARMACOL,DK-2100 COPENHAGEN,DENMARK
关键词
D O I
10.1212/WNL.34.8.1020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1020 / 1024
页数:5
相关论文
共 13 条
[1]   PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF PYRIDOSTIGMINE IN MAN [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
HARTVIG, P ;
LINDSTROM, B ;
OSTERMAN, PO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (05) :423-428
[2]  
CALVEY TN, 1977, CLIN PHARMACOL THER, V21, P187
[3]   RENAL CLEARANCE OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
CHAN, K ;
CALVEY, TN .
EUROPEAN NEUROLOGY, 1977, 16 (1-6) :69-72
[4]  
CHAN K, 1981, METHOD FIND EXP CLIN, V3, P291
[5]  
CHAN K, 1978, CLIN PHARMACOL THER, V22, P596
[6]   MALABSORPTION OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
COHAN, SL ;
DRETCHEN, KL ;
NEAL, A .
NEUROLOGY, 1977, 27 (03) :299-301
[7]   PHARMACOKINETICS OF PYRIDOSTIGMINE [J].
COHAN, SL ;
POHLMANN, JLW ;
MIKSZEWSKI, J ;
ODOHERTY, DS .
NEUROLOGY, 1976, 26 (06) :536-539
[8]   THE RELATIONSHIP OF PLASMA-LEVELS OF PYRIDOSTIGMINE TO CLINICAL EFFECT IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
DAVISON, SC ;
HYMAN, NM ;
DEHGHAN, A ;
CHAN, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (12) :1141-1145
[9]   REVERSED-PHASE, ION-PAIR LIQUID-CHROMATOGRAPHY OF QUATERNARY AMMONIUM-COMPOUNDS - DETERMINATION OF PYRIDOSTIGMINE, NEOSTIGMINE AND EDROPHONIUM IN BIOLOGICAL-FLUIDS [J].
DERUYTER, MGM ;
CRONNELLY, R ;
CASTAGNOLI, N .
JOURNAL OF CHROMATOGRAPHY, 1980, 183 (02) :193-201
[10]   METABOLISM OF C-14-LABELED PYRIDOSTIGMINE IN MYASTHENIA GRAVIS - EVIDENCE FOR MULTIPLE METABOLITES [J].
KORNFELD, P ;
SAMUELS, AJ ;
WOLF, RL ;
OSSERMAN, KE .
NEUROLOGY, 1970, 20 (07) :634-&